The Beauty Capital thesis.
How profit-linked instruments unlock dermatology infrastructure at scale — and why the next decade of beauty will be financed, not just funded.
Conclusions, theses, and working documents from the OORA Capital research team. Notes on profit-linked instruments, Indonesian yield, RWA tokenization, and the beauty capital thesis. Published on no schedule. Peruse at your leisure.
How profit-linked instruments unlock dermatology infrastructure at scale — and why the next decade of beauty will be financed, not just funded.
Treasury management in elevated base-rate environments. Notes on SBN, currency, and the floor underneath the operating business.
The clinical lead behind the OORA Skinlabs protocol — background, philosophy, and the practitioner's view on building a durable beauty platform.
The K-beauty standard outside Korea: what travels, what doesn't, and why the clinical layer matters more than the brand layer.
A close look at the technology platform powering the next phase — what it does, why it matters, and how it integrates into the OORA clinical stack.
What we look for, what we pass on, and the disciplines that separate venture capital from optionality theatre.